Table 2 of van de Ven, Mol Vis 2012; 18:2271-2278.


Table 2. Risk allele frequencies in “non CD” AMD, CD and control individuals

      “non CD” AMD/controls   CD/controls CD/”non CD” AMD
  Controls (%) “non CD” AMD (%) p-value OR (95-C.I.) CD (%) p-value OR (95-C.I.) p-value OR (95-C.I.)
rs10490924/ ARMS2 A69S 21.9 42.9 2.0×10−21 2.94 (2.35–3.67) 38.3 1.7×10−9 2.25 (1.73–2.93) 0.140 0.83 (0.64–1.06)
rs1061170/ CFH Y402H 38.1 57.7 1.9×10−14 2.17 (1.78–2.65) 64.1 8.6×10−16 2.88 (2.23–3.73) 0.022 1.35 (1.04–1.74)
rs1410996/ CFH 56.9 74.8 9.7×10−15 2.25 (1.83–2.76) 76.8 3.0×10−11 2.53 (1.93–3.33) 0.209 1.20 (0.90–1.61)
rs9332739/ C2 E318D 4.7 2.5 0.004 0.47 (0.28–0.79) 1.9 0.016 0.38 (0.17–0.83) 0.744 0.86 (0.34–2.15)
rs2230199/ C3 R102G 20.8 27.4 0.001 1.46 (1.18–1.80) 27.9 0.013 1.42 (1.08–1.88) 0.965 1.01 (0.77–1.32)
rs4151667/ CFB H9L 4.9 2.8 0.006 0.49 (0.29–0.82) 2.3 0.027 0.42 (0.19–0.91) 0.750 0.86 (0.35–2.14)
rs10033900/ CFI 48.2 51.8 0.101 1.17 (0.97–1.42) 51.5 0.232 1.16 (0.91–1.49) 0.809 1.03 (0.79–1.35)
rs7412/ APOE2 8.0 10.7 0.115 1.29 (0.94–1.77) 12.1 0.011 1.65 (1.12–2.42) 0.131 1.37 (0.91–2.05)
rs429358/ APOE4 14.4 10.2 0.058 0.74 (0.54–1.01) 11.1 0.047 0.68 (0.46–1.00) 0.660 0.91 (0.59–1.40)